Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trial
利用基于约束无序原理的第二代人工智能治疗方案提高部分缓解患者对乐伐替尼的反应:一项概念验证性开放标签临床试验
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1426426
Sigawi, Tal; Gelman, Ram; Maimon, Ofra; Yossef, Amal; Hemed, Nila; Agus, Samuel; Berg, Marc; Ilan, Yaron; Popovtzer, Aron